Daily non-political popular news in brief.

First look at an enzyme target for antibacterial and cancer drugs

The veil has finally been lifted on an enzyme that is critical to the process of DNA transcription and replication, and is a prime target of antibacterial and anticancer drugs. Researchers with the US Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeleyhave produced the first three-dimensional structural images of a DNA-bound Type II topoisomerase (topo II) that is responsible for untangling coiled strands of the chromosome during cell division.

Read more »

Keywords: look, enzyme, target, antibacterial, cancer, drugs, drug

« Previous | Next »

Similar news on "First look at an enzyme target for antibacterial and cancer drugs":

1. Enzyme structure reveals new drug targets for cancer and other diseases
   02-14-2008 · EurekAlert!
   Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
   Similar news · Read more »
   
2. Unstable leukemia stem cells may predispose patients to drug resistance
   05-01-2007 · EurekAlert!
   The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
   Similar news · Read more »
   
3. Weill Cornell team identifies potential new cancer drug target
   06-21-2007 · EurekAlert!
   Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.
   Similar news · Read more »
   
4. Study: Re-engineered Gleevec reduces heart risks
   12-03-2007 · EurekAlert!
   Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib -- best known by its brand name Gleevec -- to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect. The re-design strategy employed in the study is broadly applicable to reducing side effects in other drugs.
   Similar news · Read more »
   
5. Cell skeleton may hold key to overcoming drug resistance in cancer
   10-03-2007 · EurekAlert!
   Researchers have uncovered a new way in which a cell protein protects cancer cellsfrom a wide range of chemotherapeutic drugs, identifying a possible target forimproving treatment outcomes for patients.
   Similar news · Read more »
   
6. Lung cancer cells' survival gene seen as drug target
   12-24-2007 · EurekAlert!
   When a key gene called 14-3-3zeta is silenced, lung cancer cells can't survive on their own, researchers have found. The gene is a potential target for selective anticancer drugs.
   Similar news · Read more »
   
7. Lung cancer cells' survival gene seen as drug target
   12-31-2007 · EurekAlert!
   When a key gene called 14-3-3zeta is silenced, lung cancer cells can't survive on their own, researchers have found. The gene is a potential target for selective anticancer drugs.
   Similar news · Read more »
   
8. Telomerase enzyme structure provides significant new target for anti-cancer therapies
   11-13-2007 · EurekAlert!
   Inappropriate activation of a single enzyme, telomerase, is associated with the uncontrollable proliferation of cells seen in as many as 90 percent of all of human cancers. Scientists have long eyed the enzyme as an ideal target for developing broadly effective anti-cancer drugs. Now, researchers working at the Wistar Institute have brought this goal closer by deciphering the 3-D structure of a domain, or region, of the telomerase molecule essential for the enzyme's activity.
   Similar news · Read more »
   
9. Manic phase of bipolar disorder benefits from breast cancer medication
   09-12-2007 · EurekAlert!
   The manic phase of bipolar disorder favors destructive behaviors. Stemming it quickly is important. Tamoxifen's effects were dramatic -- 63 percent of patients responded vs. 13 percent on placebo -- and it kicked in faster than many current medications. Tamoxifen skips some of current drugs' biochemical steps and acts directly on the enzyme protein-kinase C, giving scientists a more direct target at which to aim new medications in their search for faster-acting treatments.
   Similar news · Read more »
   
10. A new target for the treatment of breast cancer
    01-11-2007 · EurekAlert!
    The active ingredient in a drug currently being tested to treat rheumatoid arthritis might also one day serve as an effective means of treating one of the deadliest forms of breast cancer. Berkeley Lab researchers have demonstrated that inhibiting the activity of the protease enzyme known as TACE can deprive tumor cells of a key factor needed for their proliferation. TACE is strongly present in a form of breast cancer which responds poorly to current therapies.
    Similar news · Read more »